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Summary
Nanoparticles (NPs), particles having one or more
dimensions below 100 nm, are currently being syn-
thesized through chemical and physical methods on
an industrial scale. However, these methods for the
synthesis of NPs do not fit with sustainable develop-
ment goals. NP synthesis, through chemical and
physical methods, requires high temperatures and/or
pressures resulting in high energy consumption and
the generation of large amounts of waste. In recent
years, research into the synthesis of NPs has shifted
to more green and biological methods, often using
microorganisms. A biological approach has many
advantages over chemical and physical methods.
Reactions are catalysed in aqueous solutions at
standard temperature and pressure (cost effective
and low energy syntheses). This method does not
require solvents or harmful chemicals, making NP
biosynthesis a greener and more eco-friendly
method. Furthermore, NP synthesis by microbes
does not require the use of pure starting materials;
thus it can simultaneously be used for the bioreme-
diation of contaminated water, land and waste, and
the biosynthesis of NPs. Therefore the biosynthesis
of NPs contributes to the sustainable development
goals, while the alternative physical and chemical
methods exclusively utilize scarce and expensive
resources for NP synthesis.
Nanoparticles (NPs), particles having one or more
dimensions below 100 nm, are currently being synthe-
sized through chemical and physical methods on an
industrial scale. However, these methods for the
synthesis of NPs do not fit with sustainable development
goals. NP synthesis, through chemical and physical
methods, requires high temperatures and/or pressures
resulting in high energy consumption and the generation
of large amounts of waste. In recent years, research into
the synthesis of NPs has shifted to more green and bio-
logical methods, often using microorganisms. A biologi-
cal approach has many advantages over chemical and
physical methods. Reactions are catalysed in aqueous
solutions at standard temperature and pressure (cost-
effective and low-energy syntheses). This method does
not require solvents or harmful chemicals, making NP
biosynthesis a greener and more eco-friendly method.
Furthermore, NP synthesis by microbes does not require
the use of pure starting materials; thus, it can simultane-
ously be used for the bioremediation of contaminated
water, land and waste and the biosynthesis of NPs (Poll-
man et al., 2006; Macaskie et al., 2010). Therefore, the
biosynthesis of NPs contributes to the sustainable devel-
opment goals, while the alternative physical and chemi-
cal methods exclusively utilize scarce and expensive
resources for NP synthesis.
Biogenic metal nanoparticles are produced by microor-
ganisms utilizing their natural metal resistance and meta-
bolic pathways, through either an intracellular or an
extracellular mechanism. The intracellular mechanism
involves ion transportation into the microbial cell where
they are then reduced to their elemental form through
electrostatic and enzymatic interactions, forming NPs
that can be held within the cell. The extracellular mecha-
nism is mediated either through enzymatic reduction at
the cell surface or by secreted molecules that reduce
metal ions into their elemental form (Hulkoti and Tara-
nath, 2014).
Potential applications of biogenic metal NPs range
from various biomedical purposes (e.g. antiviral, antibac-
terial, antiparasite, medical imaging, drug delivery, can-
cer treatment and medical diagnostics), through
environmental remediation purposes (e.g. contaminant/
pollutant degradation and catalytic treatments of aque-
ous organic compounds), to industrial purposes (e.g.
enhance fuel cell performance, catalytic organic synthe-
sis and nanoelectrochemistry) (Schr€ofel et al., 2014).
While research using biogenic nanoparticles is relatively
new, researchers are testing them for potential applica-
tions in biomedical contexts (anticancer, drug delivery
and antimicrobial). For instance, AgNPs produced by
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Bacillus licheniformis have the potential for use as an
antiagiogenic (inhibit blood vessel formation to prevent
the systemic spread of cancer cells) (Kalishwaralal et al.,
2009), while AgNPs produced by Fusarium oxyporum
have been incorporated into textile fabrics to inhibit or
prevent infections from pathogenic bacteria (Duran et al.,
2007). Nanomedicine is a growing scientific field and
has tremendous prospects for the improvement of the
diagnosis and treatment of human diseases, where bio-
genic NPs will not only be applied, but their production
will also fit within sustainable development goals.
Some examples of microorganisms that are capable of
synthesizing NPs are as follows: Desulfovibrio desulfuri-
cans, Cupriavidus metallidurans, Bacillus subtilis,
Escherichia coli, Rhodococcus sp., Candida glabrata
and Verticillium sp. (Park et al., 2015). Currently, the
range of metals that are able to be produced in nanopar-
ticle form by microbes include (but is not limited to) As,
Ag, Al, Au, Cd, Cr, Cu, As, Pb, Pd and Pt (Pantidos and
Horsfall, 2014).
Although microbially produced metal NPs have many
potential applications, there are still many drawbacks
and problems to be addressed in their synthesis. First,
biogenic metal NPs may be produced with a broad mor-
phology and size range. Second, their synthesis may not
result in sufficiently high yields and, depending on the
microorganism used, it may be slow. Third, metal NPs
are sometimes synthesized in unstable forms with
reduced catalytic activities, and finally, the use of impure
starting materials (e.g. waste) affects its downstream
purification. In an effort to address these problems, syn-
thetic biology, nanobiotechnology and genetic engineer-
ing are being researched to improve NP synthesis. Once
size and morphology are controlled, yield is increased
and downstream purification enhanced; the overall pro-
duction of NPs will be both cost-effective and greener
(Edmundson et al., 2014).
Synthetic biology involves the design and engineering
of microorganisms to make them capable of performing
novel functions for industry, medicine and scientific
research. Within the different applications of synthetic
biology are those exploring the potential biosynthesis of
metal NPs and will utilize its modular genetic engineer-
ing approach to enhance NP quality and quantity.
Research with cell surface engineering for the synthe-
sis of metal NPs has been carried out through the
heterologous expression of synthetic chelatins (polypep-
tide chelators rich in metal binding amino acids, e.g.
EC20), phytochelatins and metallothionein (cysteine-rich
polypeptide chelators found in plants) and phytochelatin
synthase (the enzyme responsible for synthesizing phy-
tochelatins from glutathione). An early synthetic biology
study successfully synthesized Au, Ag, Fe, Te, CdZn,
CdSe, CdTe, ZnSe, CdCs, PrGd, SrGd, SrPr, FeAg,
FeCo, FeMn, CdSeZn, FeCoNi, FeCoMn, CdSeZnTe
and AuCdSeZn NPs with a recombinant E. coli strain
co-expressing phytochelatin synthase and metalloth-
ionein (Park et al., 2010). While more recently the
in vivo synthesis of EuSe NPs was performed using
recombinant E. coli cells expressing phytochelatin syn-
thase, phytochelatins and metallothionein, these EuSe
NPs exhibited high fluorescence intensities and strong
magnetic properties, and their anticancer properties were
demonstrated effectively (Kim et al., 2016).
The overexpression of key proteins and enzymes from
the NP synthesis pathway can enhance a microorgan-
ism’s ability to sequester metals and significantly
increase their tolerance to metal concentrations. A recent
study produced a recombinant E. coli strain containing
arsenic resistance genes from a number of sources, and
it was then demonstrated that the engineered E. coli is
able to not only tolerate high levels of arsenic, but is also
able to convert the arsenic to an insoluble form, thereby
removing significant amounts of arsenic from a solution
(Edmundson and Horsfall, 2015).
The use of encapsulins also has promising applica-
tions within nanobiotechnology. The ability to engineer
cellular compartments and functional nanoarchitectures
under environmentally sustainable conditions has been
fruitful for the synthesis of monodispersed NPs. A recent
study engineered the Thermotoga maritima encapsulin
to yield a designed compartment for the size-constrained
synthesis of Ag NPs. Such NPs exhibited a uniform
shape and size distribution as well as long-term stability.
When their antimicrobial activity was tested, it proved to
be superior to that of silver nitrate and citrate-capped Ag
NPs (Giessen and Silver, 2016). Another promising
application of nanobiotechnology for the synthesis of
monodispersed NPs is through the use of Dps proteins,
oligomeric cage-like molecules that contain ferroxidase
centres with iron oxidation/storage capacity. Research
on Dps proteins from starved Listeria innocua cells, and
its mutant (lacking catalytic ferroxidase centre) showed
they can produce magnetite (Fe3O4) NPs, homogeneous
NPs with an average diameter of 3 nm inside both non-
mutant and mutant cavities (Ceci et al., 2010). An alter-
native method for the synthesis of magnetite is through
the biomineralization of iron with bacterial organelles
called magnetosomes. Mms6, a magnetosome protein
produced by the magnetotactic bacterium Magnetospiril-
lum magneticum AMB-1, has been shown to form mag-
netite NPs in vitro. Recent work which fused Mms6 onto
microcontact-printed assembled monolayer surfaces
showed control of the formation and location of mag-
netite NP production in microscale arrays, thus creating
magnetic NP patterns (Bird et al., 2016).
Demands for metal NPs have increased as the number
of potential applications has grown. But it is hard to
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cheaply mass-produce homogenous metal NPs, and no
method for the production of biogenic metal NPs has been
commercialized. However, recent studies have proved
that the scaled-up production of metal NPs, and therefore
its future commercialization, is a real possibility (Moon
et al., 2010; Byrne et al., 2015). The production of mag-
netite nanoparticles by the Fe(III)-reducing bacterium
Geobacter sulfurreducens has successfully been scaled
up from the laboratory to pilot plant. The plant-scale pro-
duction produced up to 120 g of biomagnetite, with a
maintained size distribution between 10 and 15 nm, and
unchanged surface reactivity and magnetic properties
(Byrne et al., 2015). Another recent study illustrating the
potential for the commercialization of biogenic NP synthe-
sis performed scale-up experiments with Thermoanaer-
obacter sp. TOR-39 (anaerobe Fe(III)-reducing bacteria),
using a 35 l reactor batch fermentation to obtain a yield of
over 1 kg (wet weight) of magnetite in less than a month
(Moon et al., 2010). Three key aspects for the mass pro-
duction of NPs through a bacterial fermentation were elu-
cidated in these studies: first, the rate at which particles
are produced; second, the size reproducibility (monodis-
persed NPs); and finally, the ease of downstream recov-
ery. However, the ultimate determinant as to the success
of industrial nanoparticles biosynthesis will be the quality
of the microbially produced NPs as compared to those
produced chemically (Delay and Frimmel, 2012).
The future of microbially produced NPs is likely to
involve an increase in the range of metals that microbes
can produce NPs from, perhaps to even include nanopar-
ticles made of metals which may not have a chemically
derived counterpart. To achieve the aforementioned, the
screening of metal NP synthesis from different microor-
ganisms needs to be conducted. Such an approach iden-
tified the CuNPs synthesized by Morganella morganii,
which are far more stable than their commercial counter-
part (Ramanathan et al., 2013). A microbial process to
produce such NPs on an industrial scale could hypotheti-
cally cost a fraction of what a traditional chemical synthe-
sis would cost. If an adequate design of a large-scale
bioreactor configuration for the optimization of NPs syn-
thesis is reached and recovery methods are perfected,
the future industrial production of biogenic metal NPs
seems like a real possibility. Not only would the mass pro-
duction of biogenic metal NPs be of importance to the sci-
entific world, but it could potentially benefit our society
and the environment, generating wealth through the
clean-up of metal-contaminated land, water and waste
sites and obtaining a final product (metal NPs) that can be
reintroduced into the world’s economy.
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